2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Vulvovaginal Atrophy: new trials by email Literature Review of Vulvovaginal Atrophy trials Research Report on Vulvovaginal Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women IVR Dose 1, IVR Dose 2 - Vulvovaginal Atrophy, Vasomotor Symptoms | Phase 1 / Phase 2 | Completed | Daré Bioscience, Inc. | 21 | 2022-04-11 | 2024-10-31 |
| A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women IVR Dose 1, IVR Dose 2, Oral Reference - Vulvovaginal Atrophy, Vasomotor Symptoms | Phase 1 | Completed | Daré Bioscience, Inc. | 34 | 2020-08-18 | 2024-10-15 |
Australia (2)